Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the fate of WeightWatchers, which declared bankruptcy this week, citing vastly increased use of the new blockbuster medicines.
Trending
- Trump’s arch plan and the history of gateways
- Disney to celebrate Winnie the Pooh's 100th birthday with year-long celebration
- Judges uphold decision to drop terrorism case against Kneecap member | UK News
- UK deploys warship in the Mediterranean to protect British bases in Cyprus
- Film show: 'The Bride!' puts Frankenstein in the shade
- Germany, others partially release oil reserves amid Iran war
- How AI can identify breast cancer ‘better’ than a doctor but there’s a catch | Science, Climate & Tech News
- 'Icky and heartbreaking': The $2 per hour worker behind the OnlyFans boom
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
By Reuters Econ
